These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7037389)

  • 1. Immunotoxicology in the pharmaceutical industry.
    Norbury KC
    Environ Health Perspect; 1982 Feb; 43():53-9. PubMed ID: 7037389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic effects of cyclophosphamide treatment in rheumatoid arthritis.
    Alepa FP; Zvaifler NJ; Sliwinski AJ
    Arthritis Rheum; 1970; 13(6):754-60. PubMed ID: 5495387
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of immunosuppressive drugs on human immunocompetence.
    Schellekens PT; Ten Berge RJ
    Pharm Weekbl Sci; 1984 Feb; 6(1):32-8. PubMed ID: 6608717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of immunobiological effects induced by chemicals, drugs or food additives. I. Tier testing and screening approach.
    Dean JH; Padarathsingh ML; Jerrells TR
    Drug Chem Toxicol; 1979; 2(1-2):5-17. PubMed ID: 548256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotoxicology.
    Miller K
    Clin Exp Immunol; 1985 Aug; 61(2):219-23. PubMed ID: 2994925
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro evaluation of drug-induced toxic effects on the immune system as assessed by proliferative assays and cytokine production.
    Pallardy M; Lebrec H; Blot C; Burleson GR; Bohuon C
    Eur Cytokine Netw; 1991; 2(3):201-6. PubMed ID: 1893072
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunotoxicology assessment in the pharmaceutical industry.
    Dean JH; Hincks JR; Remandet B
    Toxicol Lett; 1998 Dec; 102-103():247-55. PubMed ID: 10022261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical-induced immunomodulation.
    Koller LD
    J Am Vet Med Assoc; 1982 Nov; 181(10):1102-6. PubMed ID: 6816774
    [No Abstract]   [Full Text] [Related]  

  • 9. New approaches to immunotoxicity testing.
    Archer DL
    Environ Health Perspect; 1982 Feb; 43():109-13. PubMed ID: 7037382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vivo model for assessing effects of drugs and toxicants on immunocompetence.
    Speirs RS; Speirs EE
    Drug Chem Toxicol; 1979; 2(1-2):19-33. PubMed ID: 548253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune function tests for hazard identification: a paradigm shift in drug development.
    Gore ER
    Basic Clin Pharmacol Toxicol; 2006 Apr; 98(4):331-5. PubMed ID: 16623854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulating effects of BM 12.531 in animals and tolerance in man.
    Bicker U
    Cancer Treat Rep; 1978 Nov; 62(11):1987-96. PubMed ID: 728913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune function of young adult mice following in utero exposure to cyclophosphamide.
    Luebke RW; Riddle MM; Rogers RR; Garner RJ; Rowe DG; Smialowicz RJ
    J Toxicol Environ Health; 1986; 18(1):25-39. PubMed ID: 3701880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The international harmonisation of guidelines in the future: a viewpoint from the industry.
    Ekman L
    Toxicol Lett; 1998 Dec; 102-103():551-5. PubMed ID: 10022311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cyclophosphamide on immune system and gut microbiota in mice.
    Xu X; Zhang X
    Microbiol Res; 2015 Feb; 171():97-106. PubMed ID: 25553830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory immunotoxicology: does the published evidence support mandatory nonclinical immune function screening in drug development?
    Snodin DJ
    Regul Toxicol Pharmacol; 2004 Dec; 40(3):336-55. PubMed ID: 15546688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The immunocorrective activity of myelopeptide-1 and myelopeptide-2 in cyclophosphane-treated mice].
    Shanurin SIu; Belevskaia RG; Mikhaĭlova AA; Shanurin MIu
    Eksp Klin Farmakol; 1995; 58(5):53-6. PubMed ID: 8704592
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunotoxicology].
    Hanke J; Indulski JA
    Med Pr; 1988; 39(3):186-92. PubMed ID: 3067044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological aspects of toxicology: premises not promises.
    Yoshida S; Golub MS; Gershwin ME
    Regul Toxicol Pharmacol; 1989 Feb; 9(1):56-80. PubMed ID: 2667038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of progress in immunotoxicology--1983.
    Loose LD
    Surv Immunol Res; 1984; 3(2-3):238-40. PubMed ID: 6718852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.